Asia Pacific Cardiac Biomarkers Testing Market By Type (Creatine Kinase (CK-MB), Troponins, Myoglobin, Natriuretic Peptides (BNP and NT-proBNP), Ischemia Modified Albumin and Others), By Application (Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis and Others), By Location of Testing (Point of Care Testing and Laboratory Testing)
Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
Get in-depth analysis of the COVID-19 impact on the Asia Pacific Cardiac Biomarkers Testing Market
Market Report Description
The Asia Pacific Cardiac Biomarkers Testing Market would witness market growth of 12.8% CAGR during the forecast period (2019-2025). Asia Pacific would emerge as one of the most lucrative regions for Cardiac Biomarkers testing market. Prime factor fueling the growth of Asia Pacific region includes the presence of a large number of undiagnosed cardiac patients, rapid urbanization, rising disposable income, and growing awareness about cardiac disease management programs i.e. Quick cardiac checkup (QCC).
Preventing heart disease by tracking heart conditions through cardiac biomarker screening is the profound strategy for achieving rapid results for instant diagnosis and therapy. Cardiac biomarkers are traceable protein-based materials used as an indicator of the biological state and used for heart-related educational and prognostic reasons. Cardiac biomarkers are used as risk stratification for various cardiovascular diseases (CVDs), which include myocardial infarction, congestive heart failure, acute coronary syndrome (ACS) among others. The cardiac biomarkers used widely as an integrated diagnostic approach for cardiovascular diseases include CK-MB, myoglobin, troponin I and T, BNPs, IMA, and many others.
Based on Type, the market is segmented into Creatine Kinase (CK-MB), Troponins, Myoglobin, Natriuretic Peptides (BNP and NT-proBNP), Ischemia Modified Albumin and Others. Based on Application, the market is segmented into Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis and Others. Based on Location of Testing, the market is segmented into Point of Care Testing and Laboratory Testing. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Trivitron Healthcare Pvt. Ltd., ABBOTT Laboratories, Siemens AG, Becton, Dickinson AND Company, Bio-Rad laboratories, Inc., Randox Laboratories Limited, Danaher Corporation, Thermo Fisher Scientific, Inc., Johnson and Johnson and Quidel Corporation.
Scope of the Cardiac Biomarkers Testing Market Analysis
Market Segmentation:
By Type
- Creatine Kinase (CK-MB)
- Troponins
- Myoglobin
- Natriuretic Peptides (BNP and NT-proBNP)
- Ischemia Modified Albumin
- Others
By Application
- Myocardial Infarction
- Congestive Heart Failure
- Acute Coronary Syndrome
- Atherosclerosis
- Others
By Location of Testing
- Point of Care Testing
- Laboratory Testing
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Companies Profiled
- Trivitron Healthcare Pvt. Ltd.
- Abbott Laboratories
- Siemens AG
- Becton, Dickinson AND Company
- Bio-Rad Laboratories, Inc.
- Randox Laboratories Limited
- Danaher Corporation
- Thermo Fisher Scientific, Inc.
- Johnson and Johnson
- Quidel Corporation
Unique Offerings from KBV Research
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free